Drug Detail

Information about BAY80-6946 + BAY86-9766

Generic Name
IND	BAY80-6946 + BAY86-9766
Brand Name (US)
Manufacturer	Bayer
Drug Type
Delivery	Intravenous
Approval Status
Indications
Overall Strategy	Oncogenic Signal Path Based
Strategy	Block related tumor signal paths
Drug Category	PI3K inhibitor + MEK inhibitor

Links
Trials of this drug
	Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With MEK (Mitogen-activated Protein Kinase) Inhibitor BAY86-9766 in Patients With Advanced Cancer

Trial results